BioSpace News Archive

St. Jude Children’s Research Hospital® patient Gabe recently took his first steps since his treatment began more than a year ago alongside his friend, role model and four-time supercross champion Ryan Dungey at the St. Jude Walk/Run Twin Cities.

In today’s era of rising drug prices and health insurance costs, a growing number of United States healthcare consumers appear to be at a disadvantage when it comes to obtaining and staying on the treatment that’s best for them.

BlueRock Therapeutics, today announced that Emile Nuwaysir, Ph.D., Chief Executive Officer of BlueRock and Vice Chairman of the Alliance for Regenerative Medicine (ARM), will present at the Cell & Gene Meeting on the Mesa, to be held Oct. 2-4 in Carlsbad, Calif.

Sixty-seven percent of all provider organizations in the United States attest the accuracy of their provider directories, credentialing, and other demographic data through the industry-leading, multi-payer intelligent portal of Availity, the nation’s largest real-time health information network.

The Arizona Bioindustry Association (AZBio) today announced that Marti Lindsey, PhD, community engagement director for the Southwest Environmental Health Sciences Center at the University of Arizona College of Pharmacy and director of the KEYS High School Student Internship program at the UA BIO5 Institute, will be honored as the Michael A. Cusanovich Arizona Bioscience Educator of the Year at the AZBio Awards on Oct. 2, 2019.

Certara®, the global model-informed drug development and decision support leader, today announced that the US Food and Drug Administration (FDA) has renewed its legacy licenses for Synchrogenix’s electronic Common Technical Document (eCTD) review software, GlobalSubmit REVIEW™ and GlobalSubmit VALIDATE™ for another year.

BioTalent Canada marked this year’s Global Biotech Week with the announcement of the release of their fifth annual National Compensation Guide for Canada’s bio-economy.

Vital Metrix, Inc. today announced that MedTech Breakthrough, an independent organization that recognizes the top companies and solutions in the global health and medical technology market, has selected the company as the winner of its “Best Biometric Sensor Solution” award in the 2019 MedTech Breakthrough Awards program.

Hensler Surgical Technologies (HST), in partnership with Ohio native Foot & Ankle Surgeon, Peter Highlander, MD, today announced two new patent-pending Orthopedic applications.

Oragenics, Inc. (NYSE American: OGEN), a leader in the development of new antibiotics against infectious diseases and effective treatments for oral mucositis, today announces it has enrolled 158 patients in its Phase 2 trial of AG013 for the treatment of severe oral mucositis.